Back

A Cellular Cytotoxicity Assay using Ready-to-Thaw Target Cells without Washing Steps

Storm, J.; Kusch, N.; Guettler, M.; Fode, C.; Breuer, L.; Bartling, J.; Knabbe, C.; Kaltschmidt, B.; Kaltschmidt, C.

2026-01-23 immunology
10.64898/2026.01.21.700863 bioRxiv
Show abstract

Functional testing of cytotoxic lymphocytes is essential for research and quality control (QC), but most assays require freshly prepared target cells and extensive handling. A ready-to-thaw, no-wash, flow cytometry-based cytotoxicity assay was developed using pre-labeled K562 targets cryopreserved in STEM-CELLBANKER(R) EX (SCB) as suitably sized aliquots. SCB tolerability was evaluated in K562, NK-92, and primary natural killer (NK) cells; post-cryopreservation label stability of CellTrace Violet (CTV) and carboxyfluorescein succinimidyl ester (CFSE) was assessed; freezing and thawing conditions were optimized; and wash versus no-wash workflows were compared using viability-based and absolute-count readouts, across effector-to-target (E:T) ratios with NK donors and NK-92 cells. Effector viability remained high at SCB concentrations up to 10%, and 5% SCB was selected for assay design. After cryopreservation, CTV labeling remained stable over the tested storage period, whereas CFSE showed substantial signal loss. Warm-medium thawing performed comparably to water-bath thawing, and the consolidated protocol (SCB plus fetal calf serum and thermal buffering) maintained high post-thaw target viability and recovery. In killing assays, lysis increased with increasing E:T ratios; omission of the post-thaw wash had minimal impact, and 5% SCB did not impair cytotoxic function. This ready-to-thaw workflow reduces hands-on time and sample manipulation, while improving standardization for reproducible results and enabling high-throughput functional testing and QC.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Cytotherapy
14 papers in training set
Top 0.1%
22.6%
2
Scientific Reports
3102 papers in training set
Top 10%
8.5%
3
Transfusion
18 papers in training set
Top 0.1%
6.4%
4
PLOS ONE
4510 papers in training set
Top 31%
4.9%
5
Clinical and Translational Science
21 papers in training set
Top 0.1%
4.4%
6
Communications Biology
886 papers in training set
Top 1%
3.7%
50% of probability mass above
7
International Journal of Molecular Sciences
453 papers in training set
Top 4%
2.6%
8
Nature Communications
4913 papers in training set
Top 48%
1.9%
9
eLife
5422 papers in training set
Top 41%
1.7%
10
Analytical Chemistry
205 papers in training set
Top 2%
1.7%
11
STAR Protocols
15 papers in training set
Top 0.1%
1.7%
12
Frontiers in Immunology
586 papers in training set
Top 4%
1.7%
13
Transplantation
13 papers in training set
Top 0.2%
1.5%
14
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.3%
1.3%
15
Nature Protocols
30 papers in training set
Top 0.1%
1.3%
16
Cytometry Part A
30 papers in training set
Top 0.2%
1.2%
17
Journal of Immunological Methods
24 papers in training set
Top 0.1%
1.1%
18
Blood Advances
54 papers in training set
Top 1%
0.9%
19
Biology Methods and Protocols
53 papers in training set
Top 2%
0.8%
20
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 6%
0.8%
21
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 10%
0.7%
22
Alzheimer's & Dementia
143 papers in training set
Top 3%
0.7%
23
Molecular & Cellular Proteomics
158 papers in training set
Top 2%
0.7%
24
Advanced Science
249 papers in training set
Top 21%
0.6%
25
Immunology & Cell Biology
11 papers in training set
Top 0.4%
0.6%
26
Nucleic Acids Research
1128 papers in training set
Top 19%
0.6%
27
The Journal of Infectious Diseases
182 papers in training set
Top 6%
0.6%
28
mAbs
28 papers in training set
Top 0.4%
0.6%
29
Nature Biomedical Engineering
42 papers in training set
Top 2%
0.6%
30
eBioMedicine
130 papers in training set
Top 5%
0.6%